\-\ Texto\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\ mildly\\ febrile\ \(0\)\
\-\ \\â\\€\\¢\\ difficult\\ to\\ arouse\ \(0\)\
\-\ \\â\\€\\¢\\ white\\ count\\ 860\\,000\ \(0\)\
\-\ \\â\\€\\¢\\ thrombocytopenia\ \(0\)\
\-\ chemotherapy\ \(327\)\
\-\ multiple\\ enhancing\\ masses\\ involving\\ both\\ cerebral\\ hemispheres\\ and\\ the\\ brain\\ stem\\.\ \(0\)\
\-\ t\\-cell\\ acute\\ lymphoblastic\\ leukemia\\ \\(all\\)\ \(0\)\
\-\ \\â\\€\\¢\\ cerebral\\ abscesses\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ cerebral\\ infarction\ \(1\)\
\-\ 2\\ year\\ old\\ boy\\ presents\\ with\\ a\\ rapid\\ decline\\ in\\ mental\\ status\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.20313149002168915\ \(0\)\
\-\ cerebral\\:\\ 0\\.16446925009800392\ \(0\)\
\-\ 860\\,000\\:\\ 0\\.16325034118456477\ \(0\)\
\-\ arouse\\:\\ 0\\.15041428228530654\ \(0\)\
\-\ lymphoblastic\\:\\ 0\\.13006961027293412\ \(0\)\
\-\ t\\-cell\\:\\ 0\\.12721496805391083\ \(0\)\
\-\ thrombocytopenia\\:\\ 0\\.12060987649948986\ \(0\)\
\-\ decline\\:\\ 0\\.10600881427052189\ \(0\)\
\-\ stem\\:\\ 0\\.09403423714228017\ \(0\)\
\-\ febrile\\:\\ 0\\.09117959492325688\ \(0\)\
\-\ abscesses\\:\\ 0\\.08938026624818933\ \(0\)\
\-\ hemispheres\\:\\ 0\\.08431182494305894\ \(0\)\
\-\ leukemia\\:\\ 0\\.08119817824302192\ \(0\)\
\-\ rapid\\:\\ 0\\.07992053247474505\ \(0\)\
\-\ mental\\:\\ 0\\.07383712382711476\ \(0\)\
\-\ difficult\\:\\ 0\\.06926564090245688\ \(0\)\
\-\ count\\:\\ 0\\.06880837029893147\ \(0\)\
\-\ mildly\\:\\ 0\\.06739571650727165\ \(0\)\
\-\ infarction\\:\\ 0\\.06467608231163129\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.05672121824334935\ \(0\)\
\-\ status\\:\\ 0\\.05648754298484543\ \(0\)\
\-\ involving\\:\\ 0\\.055526060444505435\ \(0\)\
\-\ boy\\:\\ 0\\.05379114407270317\ \(0\)\
\-\ masses\\:\\ 0\\.05349245181474235\ \(0\)\
\-\ white\\:\\ 0\\.05248341134651884\ \(0\)\
\-\ enhancing\\:\\ 0\\.04962876912749554\ \(0\)\
\-\ brain\\:\\ 0\\.047617620801902995\ \(0\)\
\-\ all\\:\\ 0\\.044757842396875754\ \(0\)\
\-\ both\\:\\ 0\\.040411110938631874\ \(0\)\
\-\ metastatic\\:\\ 0\\.03983535932622389\ \(0\)\
\-\ acute\\:\\ 0\\.039071839427898054\ \(0\)\
\-\ 2\\:\\ 0\\.03407600919463974\ \(0\)\
\-\ multiple\\:\\ 0\\.03332974080517164\ \(0\)\
\-\ presents\\:\\ 0\\.032326746213109735\ \(0\)\
\-\ disease\\:\\ 0\\.025865510022513038\ \(0\)\
\-\ year\\:\\ 0\\.017705653134683606\ \(0\)\
\-\ old\\:\\ 0\\.016202492534486197\ \(0\)\
\-\ \\(\\:\\ 0\\.013377069004515935\ \(0\)\
\-\ \\)\\:\\ 0\\.013213660965061205\ \(0\)\
\-\ to\\:\\ 0\\.007908668674870115\ \(0\)\
\-\ in\\:\\ 0\\.007803652410004721\ \(0\)\
\-\ a\\:\\ 0\\.007344440774418541\ \(0\)\
\-\ and\\:\\ 0\\.0033335001061521935\ \(0\)\
\-\ the\\:\\ 0\\.002560171938956033\ \(0\)\
\-\ with\\:\\ 0\\.0021667440016646246\ \(0\)\
\-\ \\.\\:\\ 0\\.0006573988166175236\ \(0\)\
